Thursday, October 8, 2026

International Finance

5 articles

Hong Kong VC Deals Triple as State Fund Targets AI Infrastructure, Challenging Singapore

Hong Kong VC Deals Triple as State Fund Targets AI Infrastructure, Challenging Singapore

Hong Kong's venture capital ecosystem recorded its highest deal activity in over a decade in 2025, with transaction volume tripling as the government-backed Hong Kong Investment Corporation partnered with local fund managers. The recovery centers on AI infrastructure, logistics tech, and longevity ventures, positioning the city to reclaim Asian market share lost to Singapore and mainland Chinese hubs during the pandemic freeze.

ViaNews Editorial Team•
Iran Strikes Send Global Energy Prices Soaring as Central Banks Face Stagflation Dilemma

Iran Strikes Send Global Energy Prices Soaring as Central Banks Face Stagflation Dilemma

Iranian attacks on energy infrastructure across nine countries drove European gas prices up 85% and oil past $80 per barrel, creating simultaneous inflation and recession risks. The Fed faces pressure to coordinate with Treasury on its $7 trillion balance sheet, echoing debates about central bank independence during the 1951 Fed-Treasury Accord. Markets from Seoul to New York tumbled on stagflation fears.

ViaNews Editorial Team•
Gas Prices Jump 85% After Iran Strikes Energy Sites, Fed Policy Shift Threatens Global Banks

Gas Prices Jump 85% After Iran Strikes Energy Sites, Fed Policy Shift Threatens Global Banks

Iranian strikes on energy infrastructure drove European natural gas prices up 85% and oil above $80, while proposed Federal Reserve policy changes add pressure on banks worldwide. Korean markets fell 12% and the S&P 500 dropped 2.5% as energy shocks collided with monetary uncertainty. Banks from Seoul to Frankfurt face dual risks from energy credit exposure and potential Fed-Treasury coordination that would reshape $7.7 trillion in central bank operations.

ViaNews Editorial Team•
Norwegian Investors Risk $500M Total Loss as Chinese Salmon Farm Gets 'Catastrophic' Biosecurity Rating

Norwegian Investors Risk $500M Total Loss as Chinese Salmon Farm Gets 'Catastrophic' Biosecurity Rating

Nordic Aqua's $500 million land-based salmon facility in Ningbo, China faces catastrophic biosecurity risk that could wipe out entire production from a single disease outbreak. The recirculating water system creates amplified pathogen transmission in high-density conditions, threatening Norwegian investors' capital and China's push for aquaculture self-sufficiency.

ViaNews Editorial Team•
UK Gilt Markets Face Triple Shock as Fed Leadership Transition Threatens Dollar Stability

UK Gilt Markets Face Triple Shock as Fed Leadership Transition Threatens Dollar Stability

UK Chancellor Rachel Reeves confronts narrowing fiscal space ahead of Spring Statement 2026 as gilt yields remain volatile. Federal Reserve Chair Jerome Powell's May 2026 term expiry creates monetary policy uncertainty while US Social Security faces 2032 insolvency, threatening cross-border banking stability and dollar-denominated assets held by UK financial institutions.

ViaNews Editorial Team•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,362 source documents archived
Query this data → isubstrate.com